Evolving frontiers: endovascular strategies for the treatment of delayed cerebral ischemia-Reference-Cited by-同舟云学术

Evolving frontiers: endovascular strategies for the treatment of delayed cerebral ischemia

Published:2024-01-25 Issue:0 Volume:0 Page:
ISSN:0334-1763
Container-title:Reviews in the Neurosciences
language:en
Short-container-title:

Author:

Chlorogiannis David-Dimitris¹²^ORCID,Aloizou Athina-Maria³,Mavridis Theodoros⁴⁵,Sänger Jonathan Andreas⁶,Chlorogiannis Anargyros⁷,Madouros Nikolaos⁸²^ORCID,Papanagiotou Panagiotis⁹¹⁰

Affiliation:

1. Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School , Boston , MA 02115 , USA

2. Society of Junior Doctors , 15123 Athens , Greece

3. Department of Neurology, St. Josef-Hospital , Ruhr Universität Bochum , 44791 Bochum , Germany

4. 1st Department of Neurology, Eginition Hospital, Medical School , National and Kapodistrian University of Athens , 11528 Athens , Greece

5. Department of Neurology , Tallaght University Hospital (TUH)/The Adelaide and Meath Hospital Dublin, Incorporating the National Children’s Hospital (AMNCH) , Dublin D24 NR0A , Ireland

6. Department of Radiology , Universitätsspital Zürich , 8091 Zürich , Switzerland

7. Department of Health Economics, Policy and Management , Karolinska Institutet , 171 77 Stockholm , Sweden

8. Hull University Teaching Hospitals NHS Trust , Hull HU3 2JZ , UK

9. First Department of Radiology, School of Medicine , National & Kapodistrian University of Athens, Areteion Hospital , 115 28 Athens , Greece

10. Department of Diagnostic and Interventional Neuroradiology , Hospital Bremen-Mitte/Bremen-Ost , 28205 Bremen , Germany

Abstract

Abstract Cerebral vasospasm and delayed cerebral ischemia represent a very challenging aspect of cerebrovascular pathophysiology, most commonly subarachnoid hemorrhage, with significantly high mortality if left untreated. Considerable advances have been made in medical treatment and prompt diagnosis, while newer endovascular modalities have recently been proposed for cases of resistant cerebral vasospasm. However, there is still paucity of data regarding which and whether a single endovascular technique is non inferior to the pharmacological standard of care. In this review, we aim to summarize the current funds of knowledge concerning cerebral vasospasm and the emerging role of the endovascular techniques for its treatment.

Publisher

Walter de Gruyter GmbH

Subject

General Neuroscience

Link

https://www.degruyter.com/document/doi/10.1515/revneuro-2023-0148/pdf

Reference42 articles.

1. Adami, D., Berkefeld, J., Platz, J., Konczalla, J., Pfeilschifter, W., Weidauer, S., and Wagner, M. (2019). Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: worth the risk? J. Neuroradiol. 46: 15–24, https://doi.org/10.1016/jneurad.2018.04.001.

2. Athar, M.K. and Levine, J.M. (2012). Treatment options for cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurotherapeutics 9: 37–43, https://doi.org/10.1007/s13311-011-0098-1.

3. Bauer, A.M. and Rasmussen, P.A. (2014). Treatment of intracranial vasospasm following subarachnoid hemorrhage. Front. Neurol. 5: 72, https://doi.org/10.3389/fneur.2014.00072.

4. Boulouis, G., Labeyrie, M.A., Raymond, J., Rodriguez-Regent, C., Lukaszewicz, A.C., Bresson, D., Ben Hassen, W., Trystram, D., Meder, J.F., Oppenheim, C., et al.. (2017). Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis. Eur. Radiol. 27: 3333–3342, https://doi.org/10.1007/s00330-016-4702-y.

5. Brami, J., Chousterman, B., Boulouis, G., Dorze, M.L., Majlath, M., Saint-Maurice, J.P., Civelli, V., Froelich, S., Houdart, E., and Labeyrie, M.A. (2020). Delayed cerebral infarction is systematically associated with a cerebral vasospasm of large intracranial arteries. Neurosurgery 86: E175–E183, https://doi.org/10.1093/neuros/nyz340.